Safety and Efficacy of Bexagliflozin Compared to Sitagliptin as Add-on Therapy to Metformin in Type 2 Diabetes Subjects
Public ClinicalTrials.gov record NCT03115112. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-Blind, Active-Controlled Study to Evaluate the Effects of Bexagliflozin Versus Sitagliptin in Subjects With Type 2 Diabetes Mellitus Who Have Inadequate Glycemic Control by Metformin
Study identification
- NCT ID
- NCT03115112
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Theracos
- Industry
- Enrollment
- 386 participants
Conditions and interventions
Conditions
Interventions
- Bexagliflozin Drug
- Placebo for bexagliflozin Drug
- Placebo for sitagliptin Drug
- Sitagliptin Drug
Drug
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2017
- Primary completion
- Oct 30, 2018
- Completion
- Oct 30, 2018
- Last update posted
- Jun 21, 2021
2017 – 2018
United States locations
- U.S. sites
- 10
- U.S. states
- 7
- U.S. cities
- 10
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Clinical Research Site 1357 | Lincoln | California | 95648 | — |
| Clinical Research Site 1358 | Long Beach | California | 90806 | — |
| Clinical Research Site 1361 | San Dimas | California | 91773 | — |
| Clinical Research Site 1031 | Port Orange | Florida | 32127 | — |
| Clinical Research Site 1271 | Chicago | Illinois | 60611 | — |
| Clinical Research Site 1359 | Topeka | Kansas | 66606 | — |
| Clinical Research Site 1009 | Berlin | New Jersey | 08009 | — |
| Clinical Research Site 1037 | Trenton | New Jersey | 08611 | — |
| Clinical Research Site 1008 | Munroe Falls | Ohio | 44262 | — |
| Clinical Research Site 1360 | San Antonio | Texas | 78258 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 46 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03115112, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 21, 2021 · Synced May 5, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03115112 live on ClinicalTrials.gov.